|
RAB3GAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.80990000448512E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.763520E-04 |
| Normal-vs-Stage2 |
6.531600E-02 |
| Normal-vs-Stage3 |
6.26370000311738E-09 |
| Normal-vs-Stage4 |
4.11810030520599E-10 |
| Stage1-vs-Stage2 |
5.995400E-01 |
| Stage1-vs-Stage3 |
3.097100E-03 |
| Stage1-vs-Stage4 |
1.808620E-04 |
| Stage2-vs-Stage3 |
1.597810E-02 |
| Stage2-vs-Stage4 |
6.595900E-03 |
| Stage3-vs-Stage4 |
4.551600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.18070000004944E-07 |
| Normal-vs-AfricanAmerican |
1.605899999646E-07 |
| Normal-vs-Asian |
4.312800E-01 |
| Caucasian-vs-AfricanAmerican |
5.912300E-02 |
| Caucasian-vs-Asian |
4.050200E-01 |
| AfricanAmerican-vs-Asian |
1.038370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.82250000038786E-08 |
| Normal-vs-Female |
6.47950000000064E-05 |
| Male-vs-Female |
1.784400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.444400E-02 |
| Normal-vs-Age(41-60Yrs) |
7.77600000000378E-05 |
| Normal-vs-Age(61-80Yrs) |
1.41849999524268E-08 |
| Normal-vs-Age(81-100Yrs) |
3.435400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.828800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.139600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.803200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.798200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.057400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.304600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.991200E-01 |
| Normal-vs-Grade 2 |
4.594700E-04 |
| Normal-vs-Grade 3 |
1.17799999976853E-07 |
| Normal-vs-Grade 4 |
3.88039600451862E-11 |
| Grade 1-vs-Grade 2 |
9.666400E-02 |
| Grade 1-vs-Grade 3 |
4.499000E-03 |
| Grade 1-vs-Grade 4 |
1.201060E-04 |
| Grade 2-vs-Grade 3 |
1.717800E-02 |
| Grade 2-vs-Grade 4 |
2.29099999999871E-05 |
| Grade 3-vs-Grade 4 |
1.375870E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.814400E-02 |
| Normal-vs-ccB subtype |
1.80400000493464E-08 |
| ccA subtype-vs-ccB subtype |
2.30270000000088E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59570000002329E-06 |
| Normal-vs-N1 |
8.071900E-02 |
| N0-vs-N1 |
7.305200E-01 |
|
|
